Table 4.
Outcome | β (95% CI) |
|||
---|---|---|---|---|
Female |
Male |
|||
Model 2a | Model 3b | Model 2a | Model 3b | |
LCS(Ref) | ||||
MCS | −0.284 (−1.215, −0.700)c | −0.384 (−1.898, −1.033)c | ||
HCS | −0.593 (−2.776, −2.102)c | −0.777 (−3.420, −2.495)c | ||
Social support | −0.154 (−0.063, −0.019)c | −0.124 (−0.051, −0.015)c | −0.250 (−0.107, −0.046)c | −0.180 (−0.080, −0.030)c |
β, standardized coefficient; CI, confidence interval; HCS, high character strengths; LCS, low character strengths; MCS, moderate character strengths.
Model 2: adjusted for age, education, marital status, residence, income, cancer type, time since diagnosis, treatment plan, and presence of comorbidities.
Model 3: adjusted for model 2 covariates plus character strength patterns.
Significant results at P < 0.001.